EUVIMEDEUVIMED entdecken
Crossref

Discovery of a Novel and Potent LCK Inhibitor for Leukemia Treatment via Deep Learning and Molecular Docking

Hao Guo iD, Zhe-Yuan Shen, Yong-Yi Yuan, Rou-Fen Chen, Jing-Yi Yang, Xing-Chen Liu, Qing Zhang, Qian-Ying Pan, Jian-Jun Ding, Xin-Jun He, Qing-Nan Zhang, Xiao-Wu Dong iD und 1 weitere

Journal of Chemical Information and Modeling · 24.06.2024 · 64 (12) · 4835-4849

DOI: 10.1021/acs.jcim.4c00151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 07.06.2024. Verfasst von Hao Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China. Hauptthemen laut MEDLINE: Lymphocyte Specific Protein Tyrosine Kinase p56(lck), Molecular Docking Simulation, Protein Kinase Inhibitors, Deep Learning. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocyte Specific Protein Tyrosine Kinase p56(lck)Molecular Docking SimulationProtein Kinase InhibitorsDeep LearningHumansAnimalsDrug DiscoveryAntineoplastic AgentsCell Line, TumorCell ProliferationMice

Substanzen

Lymphocyte Specific Protein Tyrosine Kinase p56(lck)Protein Kinase InhibitorsAntineoplastic AgentsLCK protein, human

Autor:innen und Institutionen

  • Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.
  • Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou 310058, China.
  • Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China.
  • School of Food Science and Technology, Jiangnan University, Wuxi 214122, China.

ORCID-Profile: Hao Guo, Xiao-Wu Dong, Ke-Shu Zhou

Förderung

  • Natural Science Foundation of Henan Province
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Henan Provincial Medical Science Building Key Program

Zitieren

APA

Guo, H., Shen, Z. Y., Yuan, Y. Y., Chen, R. F., Yang, J. Y., Liu, X. C., Zhang, Q., Pan, Q. Y., Ding, J. J., He, X. J., Zhang, Q. N., Dong, X. W., & Zhou, K. S. (2024). Discovery of a Novel and Potent LCK Inhibitor for Leukemia Treatment via Deep Learning and Molecular Docking. Journal of Chemical Information and Modeling, 64(12), 4835-4849. https://doi.org/10.1021/acs.jcim.4c00151

Vancouver

Guo H, Shen ZY, Yuan YY, Chen RF, Yang JY, Liu XC, et al. Discovery of a Novel and Potent LCK Inhibitor for Leukemia Treatment via Deep Learning and Molecular Docking. Journal of Chemical Information and Modeling. 2024;64(12):4835-4849. doi:10.1021/acs.jcim.4c00151

BibTeX
@article{Guo2024,
  author = {Guo, Hao and Shen, Zhe-Yuan and Yuan, Yong-Yi and Chen, Rou-Fen and Yang, Jing-Yi and Liu, Xing-Chen and Zhang, Qing and Pan, Qian-Ying and Ding, Jian-Jun and He, Xin-Jun and Zhang, Qing-Nan and Dong, Xiao-Wu and Zhou, Ke-Shu},
  title = {Discovery of a Novel and Potent LCK Inhibitor for Leukemia Treatment via Deep Learning and Molecular Docking},
  journal = {Journal of Chemical Information and Modeling},
  year = {2024},
  volume = {64},
  number = {12},
  pages = {4835--4849},
  doi = {10.1021/acs.jcim.4c00151}
}
Kostenlos starten →